EE+ POEM Archive
SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "SGLT-2 Inhibitors or GLP-1 Receptor Agonists Reduce Cardiovascular Outcomes in Patients With Type 2 Diabetes." EE+ POEM Archive, John Wiley & Sons, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315293/all/SGLT_2_inhibitors_or_GLP_1_receptor_agonists_reduce_cardiovascular_outcomes_in_patients_with_type_2_diabetes.
SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2024. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315293/all/SGLT_2_inhibitors_or_GLP_1_receptor_agonists_reduce_cardiovascular_outcomes_in_patients_with_type_2_diabetes. Accessed December 6, 2024.
SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes. (2024). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315293/all/SGLT_2_inhibitors_or_GLP_1_receptor_agonists_reduce_cardiovascular_outcomes_in_patients_with_type_2_diabetes
SGLT-2 Inhibitors or GLP-1 Receptor Agonists Reduce Cardiovascular Outcomes in Patients With Type 2 Diabetes [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2024. [cited 2024 December 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315293/all/SGLT_2_inhibitors_or_GLP_1_receptor_agonists_reduce_cardiovascular_outcomes_in_patients_with_type_2_diabetes.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes
ID - 1315293
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315293/all/SGLT_2_inhibitors_or_GLP_1_receptor_agonists_reduce_cardiovascular_outcomes_in_patients_with_type_2_diabetes
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
